ESC 365 - Welcome and introduction.

Open Access

Welcome and introduction.

Session: SGLT2 inhibitors in practice (part 1): what is the state of heart failure treatment in 2022?

Topic: Chronic Heart Failure, Other

Speaker: Professor J. Butler (Dallas, US)

Sponsored by Boehringer Ingelheim & Eli Lilly

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

117 presentations

18 followers

3 more presentations in this session

What is the evidence for SGLT2 inhibitors in HF?

Speaker: Professor I. Pina (Philadelphia, US)

SGLT2 inhibitors for HF treatments in 2022 - What do the guidelines tell us?

Speaker: Professor G. Rosano (London, GB)

Panel discussion.

Speaker: Professor S. Anker (Berlin, DE)

Access the full session

SGLT2 inhibitors in practice (part 1): what is the state of heart failure treatment in 2022?

Speakers: Professor J. Butler, Professor I. Pina, Professor G. Rosano, Professor S. Anker

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources